July 5, 2019
- D rug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Compliance Policy for Certain Compounding of Oral Oxitriptan (5-HTP) Drug Products for Patients With Tetrahydrobiopterin (BH4) Deficiency Immediately in Effect Guidance for Industry
- Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products
- Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Sold at Walgreens
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario